Page not found

The page you were looking for does not exist. Please try searching for what you're looking for.

Search results

  1. Family history and colon cancer

    Patients with one first-degree relative who was diagnosed with colorectal cancer or advanced adenoma ... (polyps) when younger than 60. Patients with two first-degree relatives diagnosed with colorectal cancer ... or advanced adenoma at any age. Patients with one first-degree relative diagnosed with colorectal cancer ...

  2. Patients with one first-degree relative who was diagnosed with colorectal cancer or advanced adenoma ... (polyps) when younger than 60. Patients with two first-degree relatives diagnosed with colorectal cancer ... or advanced adenoma at any age. Patients with one first-degree relative diagnosed with colorectal cancer ...

  3. Cancer Clinical Trial- Tesaro 3000-PN162-01-001

    of Niraparib in Combination With Pembrolizumab (MK-3475) in Patients With Advanced or Metastatic ... Triple-Negative Breast Cancer and in Patients With Recurrent Ovarian Cancer This Phase 1/2 study will evaluate ... the safety and efficacy of combination treatment with niraparib and pembrolizumab (MK-3475) in patients ...

  4. at HonorHealth. Patients here have access to a powerful combination of leading-edge clinical trials, top ... to teach craft classes to other cancer patients at the center. “I came through the storm,” she said of her ... Center possible so patients like Joan can enjoy improved outcomes and quality of life. Without ...

  5. Primary Care

    The HonorHealth Medical Group offers comprehensive primary care services to patients of all ages, ... care locations throughout the Valley to help you stay healthy. As a patient of HonorHealth’s network ... Bell Road Phoenix: Saguaro Peoria: Del Lago Patient-Centered Primary Care Many of the HonorHealth ...

  6. Cancer Clinical Trial- Calithera CX-839-004

    CB-839 in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma and Other Solid ... in patients with clear cell renal cell carcinoma, melanoma, and non-small cell lung cancer. Ability to provide ... Cycle 1 Day 1 Active infection requiring within 2 weeks prior to first dose of study drug Patients who ...

  7. as needed. Prescribes medications and other treatments. Manages a patient's care. Surgeons perform ... of medicine. The focus is on seeing the patient as a whole person instead of treating just the symptoms. ... a patient's muscles and joints with stretching, gentle pressure and resistance — to diagnose, treat ...

  8. percent of patients diagnosed with the disease. It's characterized by weakness in the trunk, arms ... and legs. Ocular myasthenia gravis affects about 10 to 15 percent of patients diagnosed with myasthenia ... the acetylcholine receptor in about 85 percent of generalized myasthenia gravis patients (but only 50 percent ...

  9. Myasthenia gravis

    Generalized myasthenia gravis is the type that affects between 80 and 90 percent of patients diagnosed ... about 10 to 15 percent of patients diagnosed with myasthenia gravis. Only the muscles that control eye ... directed against the acetylcholine receptor in about 85 percent of generalized myasthenia gravis patients ...

  10. Cancer Clinical Trial EPI-506-CS-0001

    Open-label Study to Assess the Safety, Pharmacokinetics, and Anti-tumor Activity of Oral EPI-506 in Patients ... and multiple-dose escalation in patients with progressive metastatic castration-resistant prostate cancer (mCRPC). ... Patients are eligible for the study if all of the following apply: Institutional Review Board ...